LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $657,000 | +214.4% | 5,752 | +245.7% | 0.00% | +300.0% |
Q1 2019 | $209,000 | -39.4% | 1,664 | -34.5% | 0.00% | -50.0% |
Q4 2018 | $345,000 | -49.0% | 2,539 | +2.9% | 0.00% | -50.0% |
Q3 2018 | $677,000 | +25.6% | 2,468 | -5.1% | 0.00% | +33.3% |
Q2 2018 | $539,000 | +25.3% | 2,600 | -0.2% | 0.00% | 0.0% |
Q1 2018 | $430,000 | +23.6% | 2,605 | +2.4% | 0.00% | +50.0% |
Q4 2017 | $348,000 | +5.8% | 2,544 | +5.3% | 0.00% | 0.0% |
Q3 2017 | $329,000 | +47.5% | 2,416 | +31.3% | 0.00% | +100.0% |
Q2 2017 | $223,000 | -7.1% | 1,840 | -18.8% | 0.00% | 0.0% |
Q1 2017 | $240,000 | – | 2,267 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |